INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 43h ago
House PTR3h ago
SEC 13F3h ago
Robinhood Chain3h ago

Most active filers · 30d

  1. 01Kurtz George0B / 215S215 trades$52.62M
  2. 02FWFogarty Patrick W0B / 150S150 trades$600K
  3. 03SPSaba Capital Management, L.P.65B / 19S · 11 late84 trades$21.64M
  4. 04ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  5. 05AJAllaire Jeremy0B / 50S50 trades$4.26M
  6. 06Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  7. 07SJSheena Jonathan0B / 45S45 trades$3.01M
  8. 08SISarowitz Steven I2B / 34S36 trades$22.46M
  9. 09SLSpeiser Michael L0B / 35S35 trades$14.00M
  10. 10RARothblatt Martine A0B / 33S33 trades$5.50M

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 1732 insiders$917K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 168 insiders$42.58M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLIBEXIBEX LtdNov 9 – Nov 167 insiders$3.36M
  7. SELLMGNIMAGNITE, INC.Nov 5 – Nov 127 insiders$2.27M
  8. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M

Form 4 transactions

72,525 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
11
IJ
Inrig JulaCHIEF MEDICAL OFFICER
TVTXTravere Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$50K
1,547 sh
Feb 4, 2026Feb 5, 2026
Page 1371 of 1814
← PrevNext →
traded Feb 4, 2026
+1d
SEC Form 4

Evidence

11
SD
Shah Nealesh D.SVP and CFO
KOSKosmos Energy Ltd.
Open-market sale · 10b5-1 plan
SELL$35K
24.7K sh
Feb 4, 2026Feb 5, 2026
traded Feb 4, 2026
+1dSEC Form 4

Evidence

11
KM
Kim Joo MiCHIEF FINANCIAL OFFICER
QLYSQUALYS, INC.
Tax withholding
F$311K
2,441 sh
Feb 3, 2026Feb 5, 2026
traded Feb 3, 2026
+2dSEC Form 4

Evidence

11
IJ
Inrig JulaCHIEF MEDICAL OFFICER
TVTXTravere Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$7,621
232 sh
Feb 4, 2026Feb 5, 2026
traded Feb 4, 2026
+1dSEC Form 4

Evidence

11
GW
Glass Ronald W.VP & Chief Accounting Officer
KOSKosmos Energy Ltd.
Open-market sale · 10b5-1 plan
SELL$4,704
3,313 sh
Feb 4, 2026Feb 5, 2026
traded Feb 4, 2026
+1dSEC Form 4

Evidence

9
HA
Hunton Matthew AEVP, President, Kemper Auto
KMPRKEMPER Corp
Grant or award
A—
27.2K sh
Feb 3, 2026Feb 5, 2026
traded Feb 3, 2026
+2dSEC Form 4

Evidence

9
BK
Balthaser KevinChief Financial Officer
ACRSAclaris Therapeutics, Inc.
Tax withholding
F$22K
6,449 sh
Feb 3, 2026Feb 5, 2026
traded Feb 3, 2026
+2dSEC Form 4

Evidence

9
EW
Eifler Robert W.Director, President & CEO
NENoble Corp plc
Option exercise
M—
20.9K sh
Feb 3, 2026Feb 5, 2026
traded Feb 3, 2026
+2dSEC Form 4

Evidence

9
CT
Camden Bradley TEVP and CFO
KMPRKEMPER Corp
Tax withholding
F$17K
453 sh
Feb 3, 2026Feb 5, 2026
traded Feb 3, 2026
+2dSEC Form 4

Evidence

9
AE
Aviles EdithDirector
SMGSCOTTS MIRACLE-GRO CO
Option exercise
M—
336 sh
Feb 3, 2026Feb 5, 2026
traded Feb 3, 2026
+2dSEC Form 4

Evidence

9
FW
Flint Christopher WadeEVP, President, Kemper Life
KMPRKEMPER Corp
Tax withholding
F$19K
507 sh
Feb 3, 2026Feb 5, 2026
traded Feb 3, 2026
+2dSEC Form 4

Evidence

9
CC
Correia ChristinaCVP , Chief Accounting Officer
LRCXLAM RESEARCH CORP
Option exercise
M—
6,030 sh
Feb 3, 2026Feb 5, 2026
traded Feb 3, 2026
+2dSEC Form 4

Evidence

9
KD
Kingdon Mark DDirector
SMGSCOTTS MIRACLE-GRO CO
Option exercise
M—
165 sh
Feb 3, 2026Feb 5, 2026
traded Feb 3, 2026
+2dSEC Form 4

Evidence

9
SC
Saldanha CraigChief Product Officer
YELPYELP INC
Grant or award
A—
19.7K sh
Feb 3, 2026Feb 5, 2026
traded Feb 3, 2026
+2dSEC Form 4

Evidence

9
BB
Barker Richard B.EVP and CFO
NENoble Corp plc
Option exercise
M—
9,644 sh
Feb 3, 2026Feb 5, 2026
traded Feb 3, 2026
+2dSEC Form 4

Evidence

9
HR
Horn David R.PRESIDENT & CFO
SEERSeer, Inc.
Grant or award
A—
79.0K sh
Feb 3, 2026Feb 5, 2026
traded Feb 3, 2026
+2dSEC Form 4

Evidence

9
KM
Kim Joo MiCHIEF FINANCIAL OFFICER
QLYSQUALYS, INC.
Grant or award
A—
5,280 sh
Feb 3, 2026Feb 5, 2026
traded Feb 3, 2026
+2dSEC Form 4

Evidence

9
RA
Rock Laura AEVP, Chief HR Officer
KMPRKEMPER Corp
Grant or award
A—
20.0K sh
Feb 3, 2026Feb 5, 2026
traded Feb 3, 2026
+2dSEC Form 4

Evidence

9
BM
Brennan Ita MDirector
PLPlanet Labs PBC
Option exercise
M—
423 sh
Feb 3, 2026Feb 5, 2026
traded Feb 3, 2026
+2dSEC Form 4

Evidence

9
CA
Combs AndrewChief Chemistry Officer
PRLDPrelude Therapeutics Inc
Grant or award
A—
230.0K sh
Feb 4, 2026Feb 5, 2026
traded Feb 4, 2026
+1dSEC Form 4

Evidence

9
VK
Vaddi KrishnaDirector, CEO
PRLDPrelude Therapeutics Inc
Grant or award
A—
837.0K sh
Feb 4, 2026Feb 5, 2026
traded Feb 4, 2026
+1dSEC Form 4

Evidence

9
AS
Arana SaraChief Accounting Officer
SSBSouthState Bank Corp
Tax withholding
F$13K
122 sh
Feb 4, 2026Feb 5, 2026
traded Feb 4, 2026
+1dSEC Form 4

Evidence

9
GD
Gizinski DanielPresident, S&S Comm. Segment
CMTLCOMTECH TELECOMMUNICATIONS CORP /DE/
Option exercise
M—
1,019 sh
Feb 4, 2026Feb 5, 2026
traded Feb 4, 2026
+1dSEC Form 4

Evidence

9
MA
Mohr Gavin A.Executive Vice President
IBCPINDEPENDENT BANK CORP /MI/
Grant or award
A—
2,037 sh
Feb 3, 2026Feb 5, 2026
traded Feb 3, 2026
+2dSEC Form 4

Evidence

9
BP
Betori Richard P.EVP; President - PeopleScout
TBITrueBlue, Inc.
Tax withholding
F$2,833
515 sh
Feb 3, 2026Feb 5, 2026
traded Feb 3, 2026
+2dSEC Form 4

Evidence

9
EC
Erb Thomas CDirector
POSTPost Holdings, Inc.
Grant or award
A—
1,600 sh
Feb 3, 2026Feb 5, 2026
traded Feb 3, 2026
+2dSEC Form 4

Evidence

9
GD
Gizinski DanielPresident, S&S Comm. Segment
CMTLCOMTECH TELECOMMUNICATIONS CORP /DE/
Option exercise
M—
1,019 sh
Feb 4, 2026Feb 5, 2026
traded Feb 4, 2026
+1dSEC Form 4

Evidence

9
RA
Ramamoorthy AnandEVP, Chief Claims Officer
KMPRKEMPER Corp
Grant or award
A—
20.0K sh
Feb 3, 2026Feb 5, 2026
traded Feb 3, 2026
+2dSEC Form 4

Evidence

9
PD
Perlis DanielEVP Sales, Mktg, Business Dev
ELSEQUITY LIFESTYLE PROPERTIES INC
Tax withholding
F$21K
327 sh
Feb 3, 2026Feb 5, 2026
traded Feb 3, 2026
+2dSEC Form 4

Evidence

9
SJ
Stodolak Michael JosephExecutive Vice President
IBCPINDEPENDENT BANK CORP /MI/
Grant or award
A—
1,532 sh
Feb 3, 2026Feb 5, 2026
traded Feb 3, 2026
+2dSEC Form 4

Evidence

9
HR
Harvey RoryExecutive Vice President
GMGeneral Motors Co
Grant or award
A—
22.3K sh
Feb 3, 2026Feb 5, 2026
traded Feb 3, 2026
+2dSEC Form 4

Evidence

9
WG
Wooley GregEXEC VP OPERATIONS
SKYWSKYWEST INC
Grant or award
A—
2,109 sh
Feb 3, 2026Feb 5, 2026
traded Feb 3, 2026
+2dSEC Form 4

Evidence

9
HA
Hunton Matthew AEVP, President, Kemper Auto
KMPRKEMPER Corp
Grant or award
A—
1,876 sh
Feb 3, 2026Feb 5, 2026
traded Feb 3, 2026
+2dSEC Form 4

Evidence

9
CM
Chu MaggieSVP, CHRO
LFUSLITTELFUSE INC /DE
Option exercise
M—
2,061 sh
Feb 4, 2026Feb 5, 2026
traded Feb 4, 2026
+1dSEC Form 4

Evidence

9
DM
Dixton Grant MichaelExecutive Vice President
GMGeneral Motors Co
Grant or award
A—
17.9K sh
Feb 3, 2026Feb 5, 2026
traded Feb 3, 2026
+2dSEC Form 4

Evidence

9
FJ
Fernandes Neil JSenior Vice President
LRCXLAM RESEARCH CORP
Option exercise
M—
14.4K sh
Feb 3, 2026Feb 5, 2026
traded Feb 3, 2026
+2dSEC Form 4

Evidence

9
CT
Camden Bradley TEVP and CFO
KMPRKEMPER Corp
Grant or award
A—
1,452 sh
Feb 3, 2026Feb 5, 2026
traded Feb 3, 2026
+2dSEC Form 4

Evidence

9
KM
Kim Joo MiCHIEF FINANCIAL OFFICER
QLYSQUALYS, INC.
Grant or award
A—
4,796 sh
Feb 3, 2026Feb 5, 2026
traded Feb 3, 2026
+2dSEC Form 4

Evidence

9
KM
Kawaja Joey MSVP, Operations
NENoble Corp plc
Option exercise
M—
3,645 sh
Feb 3, 2026Feb 5, 2026
traded Feb 3, 2026
+2dSEC Form 4

Evidence

9
SP
Scherle PeggyChief Scientific Officer
PRLDPrelude Therapeutics Inc
Grant or award
A—
230.0K sh
Feb 4, 2026Feb 5, 2026
traded Feb 4, 2026
+1dSEC Form 4

Evidence